HEGGIE THERESA bought BCRX
August 13, 2025 · Form 4 insider transaction
HEGGIE THERESA bought 40,000 shares of BioCryst Pharmaceuticals, Inc. at $5.41 per share, a transaction worth $216.4K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
40,000
Price
$5.41
Total value
$216.4K
InsiderHEGGIE THERESA
Role—
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateAugust 13, 2025
Filing dateAugust 15, 2025
Shares owned after135,352
OwnershipDirect
10b5-1 planNo
AmendedNo